Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Clinical trial NCT04710134 · COMPLETED

Trial details

NCT number: NCT04710134
Sponsor: McMaster University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Asthma; Eosinophilic

Start date: 2021-02-10
Primary completion: 2024-01-09
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.